Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-20-064018

SVP Finance, CFO acquired 5,260 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hahn Brian M. · SVP Finance, CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-16 Exercise or conversion : show line 1 in the form +5,260 $1.12 $5,891 5,260 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-16 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −5,260 0 D
Loading xslF345X03/doc4.xml…